161 related articles for article (PubMed ID: 36306722)
1. Whole-genome optical mapping to elucidate myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions.
Podvin B; Roynard P; Boudry A; Guermouche H; Daudignon A; Terriou L; Bouabdelli W; Salameh M; Grardel N; Duployez N; Roche-Lestienne C
Leuk Res; 2022 Dec; 123():106972. PubMed ID: 36306722
[No Abstract] [Full Text] [Related]
2. Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group.
Shomali W; Colucci P; George TI; Kiladjian JJ; Langford C; Patel JL; Reiter A; Vannucchi AM; Gotlib J
Leukemia; 2023 May; 37(5):981-987. PubMed ID: 37076693
[No Abstract] [Full Text] [Related]
3. Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.
Xu X; Lu Q; Wang Z; Cai P; Zeng Z; Zhang L; Wang M; Ma L; Ruan C; Chen S
Cancer Res Treat; 2021 Jul; 53(3):889-892. PubMed ID: 33421986
[TBL] [Abstract][Full Text] [Related]
4. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
[TBL] [Abstract][Full Text] [Related]
5. A
Venable ER; Gagnon MF; Pitel BA; Palmer JM; Peterson JF; Baughn LB; Hoppman NL; Greipp PT; Ketterling RP; Patnaik MS; Kelemen K; Xu X
Cold Spring Harb Mol Case Stud; 2023 Feb; 9(1):. PubMed ID: 36627146
[TBL] [Abstract][Full Text] [Related]
6. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia.
Jawhar M; Naumann N; Knut M; Score J; Ghazzawi M; Schneider B; Kreuzer KA; Hallek M; Drexler HG; Chacko J; Wallis L; Fabarius A; Metzgeroth G; Hofmann WK; Chase A; Tapper W; Reiter A; Cross NCP
Leukemia; 2017 Oct; 31(10):2271-2273. PubMed ID: 28751768
[No Abstract] [Full Text] [Related]
8. Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
Gerds AT; Gotlib J; Bose P; Deininger MW; Dunbar A; Elshoury A; George TI; Gojo I; Gundabolu K; Hexner E; Hobbs G; Jain T; Jamieson C; Kuykendall AT; McMahon B; Mohan SR; Oehler V; Oh S; Pardanani A; Podoltsev N; Ranheim E; Rein L; Salit R; Snyder DS; Stein BL; Talpaz M; Thota S; Vachhani P; Wadleigh M; Walsh K; Ward DC; Bergman MA; Sundar H
J Natl Compr Canc Netw; 2020 Sep; 18(9):1248-1269. PubMed ID: 32886902
[TBL] [Abstract][Full Text] [Related]
9. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
Zou YS; Hoppman NL; Singh ZN; Sawhney S; Kotiah SD; Baer MR
Cancer Genet; 2017 Apr; 212-213():38-44. PubMed ID: 28449810
[TBL] [Abstract][Full Text] [Related]
10. Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms.
Gosenca D; Kellert B; Metzgeroth G; Haferlach C; Fabarius A; Schwaab J; Kneba M; Scheid C; Töpelt K; Erben P; Haferlach T; Cross NC; Hofmann WK; Seifarth W; Reiter A
Genes Chromosomes Cancer; 2014 May; 53(5):411-21. PubMed ID: 24772479
[TBL] [Abstract][Full Text] [Related]
11. Myeloid neoplasms with eosinophilia.
Reiter A; Gotlib J
Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
[TBL] [Abstract][Full Text] [Related]
12. A novel WNK1::PDGFRB fusion gene in myeloid neoplasm with eosinophilia: a case report.
Wang T; Cao J; Lin Q; Liu X; Wang M; Pei R; Lu Y
Ann Hematol; 2022 Oct; 101(10):2359-2361. PubMed ID: 35759027
[No Abstract] [Full Text] [Related]
13. A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment Implications.
Gupta SK; Jain N; Tang G; Futreal A; Wang SA; Khoury JD; Yang RK; Fang H; Patel KP; Luthra R; Routbort M; Barkoh BA; Chen W; Mao X; Zhang J; Medeiros LJ; Bueso-Ramos CE; Loghavi S
J Natl Compr Canc Netw; 2020 Oct; 18(10):1300-1304. PubMed ID: 33022638
[TBL] [Abstract][Full Text] [Related]
14. Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition.
Yao J; Xu L; Aypar U; Meyerson HJ; Londono D; Gao Q; Baik J; Dietz J; Benayed R; Sigler A; Yabe M; Dogan A; Arcila ME; Roshal M; Zhang Y; Mauro MJ; Xiao W
Haematologica; 2021 Feb; 106(2):614-618. PubMed ID: 32299902
[No Abstract] [Full Text] [Related]
15. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
Savage N; George TI; Gotlib J
Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
[TBL] [Abstract][Full Text] [Related]
16. Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children.
Berking AC; Flaadt T; Behrens YL; Yoshimi A; Leipold A; Holzer U; Lang P; Quintanilla-Martinez L; Schlegelberger B; Reiter A; Niemeyer C; Strahm B; Göhring G
Cancer Genet; 2023 Apr; 272-273():29-34. PubMed ID: 36657267
[TBL] [Abstract][Full Text] [Related]
17. NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors.
Byrgazov K; Kastner R; Gorna M; Hoermann G; Koenig M; Lucini CB; Ulreich R; Benesch M; Strenger V; Lackner H; Schwinger W; Sovinz P; Haas OA; van den Heuvel-Eibrink M; Niemeyer CM; Hantschel O; Valent P; Superti-Furga G; Urban C; Dworzak MN; Lion T
Leukemia; 2017 Jan; 31(1):237-240. PubMed ID: 27573554
[No Abstract] [Full Text] [Related]
18. A novel TRIP11-FLT3 fusion in a patient with a myeloid/lymphoid neoplasm with eosinophilia.
Chung A; Hou Y; Ohgami RS; Von Gehr A; Fisk DG; Roskin KM; Li X; Gojenola L; Bangs CD; Arber DA; Fire AZ; Cherry AM; Zehnder JL; Gotlib J; Merker JD
Cancer Genet; 2017 Oct; 216-217():10-15. PubMed ID: 29025582
[TBL] [Abstract][Full Text] [Related]
19. t(9;12)(q22;p13) ETV6::SYK: A new recurrent cytogenetic aberration and tyrosine kinase gene fusion in myeloid or lymphoid neoplasms associated with eosinophilia.
Lierman E; Smits S; Debackere K; André M; Michaux L; Vandenberghe P
Br J Haematol; 2023 Mar; 200(5):665-668. PubMed ID: 36385372
[No Abstract] [Full Text] [Related]
20. BCR-JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia.
He R; Greipp PT; Rangan A; Mai M; Chen D; Reichard KK; Nelsen LL; Pardanani A; Hanson CA; Viswanatha DS
Cancer Genet; 2016 May; 209(5):223-8. PubMed ID: 27134074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
